WSJ News Exclusive | FDA Delays Moderna Covid-19 Vaccine for Adolescents to Review Rare Myocarditis Side Effect
The Food and Drug Administration is delaying a decision on authorizing Moderna Inc.’s MRNA -2.41% Covid-19 vaccine for adolescents to...
The Food and Drug Administration is delaying a decision on authorizing Moderna Inc.’s MRNA -2.41% Covid-19 vaccine for adolescents to...